Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BMY

Bristol-Myers

$52.30

-0.06 (-0.11%)

16:19
04/18/18
04/18
16:19
04/18/18
16:19
Hot Stocks
Bristol-Myers says FDA accepts sBLA for Opdivo for priority review »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    May

  • 21

    May

  • 10

    Jul

BMY

Bristol-Myers

09:31
04/18/18
04/18
09:31
04/18/18
09:31
Recommendations
Bristol-Myers analyst commentary at BMO Capital »

Bristol-Myers price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    May

  • 21

    May

  • 10

    Jul

ITUS

ITUS

$4.05

-0.31 (-7.11%)

, RCUS

Arcus Biosciences

$17.00

0.33 (1.98%)

04:55
04/18/18
04/18
04:55
04/18/18
04:55
Conference/Events
American Association for Cancer Research to hold annual meeting »

AACR Annual Meeting 2018…

ITUS

ITUS

$4.05

-0.31 (-7.11%)

RCUS

Arcus Biosciences

$17.00

0.33 (1.98%)

FATE

Fate Therapeutics

$11.53

0.36 (3.22%)

CRSP

Crispr Therapeutics

$52.75

1.73 (3.39%)

ABBV

AbbVie

$93.57

0.99 (1.07%)

ADAP

Adaptimmune

$12.33

-0.03 (-0.24%)

AMGN

Amgen

$174.95

3.58 (2.09%)

AZN

AstraZeneca

$35.85

0.105 (0.29%)

BAYRY

Bayer

BMY

Bristol-Myers

$52.36

-1.72 (-3.18%)

CYAD

Celyad

$31.00

-0.5 (-1.59%)

ECYT

Endocyte

$10.05

0.81 (8.77%)

MRK

Merck

$59.29

0.63 (1.07%)

AGLE

Aeglea BioTherapeutics

$9.40

0.35 (3.87%)

SYRS

Syros Pharmaceuticals

$13.50

0.35 (2.66%)

CRL

Charles River

$108.03

0.86 (0.80%)

IMMVF

ImmunoVaccine

VBLT

VBL Therapeutics

$2.15

-0.075 (-3.37%)

APVO

Aptevo Therapeutics

$4.34

-0.12 (-2.69%)

SYBX

Synlogic

$11.93

0.58 (5.11%)

NKTR

Nektar

$93.81

0.31 (0.33%)

LIFE

aTyr Pharma

$2.60

-0.15 (-5.45%)

SNDX

Syndax

$11.50

0.71 (6.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 20

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 24

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 30

    Apr

  • 01

    May

  • 03

    May

  • 03

    May

  • 04

    May

  • 08

    May

  • 10

    May

  • 17

    May

  • 18

    May

  • 21

    May

  • 28

    May

  • 05

    Jun

  • 12

    Jun

  • 10

    Jul

  • 23

    Oct

  • 19

    Apr

Over a week ago
PEP

PepsiCo

$108.24

-1.7 (-1.55%)

, BMY

Bristol-Myers

$52.68

-1.405 (-2.60%)

10:35
04/17/18
04/17
10:35
04/17/18
10:35
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

PEP

PepsiCo

$108.24

-1.7 (-1.55%)

BMY

Bristol-Myers

$52.68

-1.405 (-2.60%)

ACIA

Acacia Communications

$25.58

-0.04 (-0.16%)

IP

International Paper

$53.63

-0.11 (-0.20%)

WWE

WWE

$38.60

-0.89 (-2.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

  • 19

    Apr

  • 26

    Apr

  • 26

    Apr

  • 03

    May

  • 03

    May

  • 08

    May

  • 09

    May

  • 21

    May

  • 12

    Jun

  • 10

    Jul

MRK

Merck

$58.66

1.48 (2.59%)

, BMY

Bristol-Myers

$54.08

-4.56 (-7.78%)

07:49
04/17/18
04/17
07:49
04/17/18
07:49
Upgrade
Merck, Bristol-Myers rating change  »

Merck upgraded to…

MRK

Merck

$58.66

1.48 (2.59%)

BMY

Bristol-Myers

$54.08

-4.56 (-7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 23

    Apr

  • 24

    Apr

  • 26

    Apr

  • 27

    Apr

  • 01

    May

  • 08

    May

  • 21

    May

  • 05

    Jun

  • 10

    Jul

  • 23

    Oct

BMY

Bristol-Myers

$54.08

-4.56 (-7.78%)

, MRK

Merck

$58.66

1.48 (2.59%)

07:42
04/17/18
04/17
07:42
04/17/18
07:42
Downgrade
Bristol-Myers, Merck rating change at Morgan Stanley »

Bristol-Myers downgraded…

BMY

Bristol-Myers

$54.08

-4.56 (-7.78%)

MRK

Merck

$58.66

1.48 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 23

    Apr

  • 24

    Apr

  • 26

    Apr

  • 27

    Apr

  • 01

    May

  • 08

    May

  • 21

    May

  • 05

    Jun

  • 10

    Jul

  • 23

    Oct

WFC

Wells Fargo

$50.81

-0.09 (-0.18%)

, X

U.S. Steel

$35.75

0.235 (0.66%)

07:36
04/17/18
04/17
07:36
04/17/18
07:36
Options
Unusual call flow in option market yesterday »

Notable call activity was…

WFC

Wells Fargo

$50.81

-0.09 (-0.18%)

X

U.S. Steel

$35.75

0.235 (0.66%)

MRK

Merck

$58.66

1.48 (2.59%)

BMY

Bristol-Myers

$54.08

-4.56 (-7.78%)

DVN

Devon Energy

$33.61

0.02 (0.06%)

VFC

VF Corp.

$77.92

0.7 (0.91%)

CCJ

Cameco

$10.26

0.325 (3.27%)

EDU

New Oriental Education

$91.45

-0.845 (-0.92%)

PGR

Progressive

$60.94

0.88 (1.47%)

MIK

Michaels

$18.43

0.135 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 23

    Apr

  • 24

    Apr

  • 24

    Apr

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 01

    May

  • 02

    May

  • 04

    May

  • 08

    May

  • 21

    May

  • 22

    May

  • 30

    May

  • 05

    Jun

  • 10

    Jul

  • 23

    Oct

NKTR

Nektar

$93.50

-6.98 (-6.95%)

, BMY

Bristol-Myers

$54.08

-4.56 (-7.78%)

07:18
04/17/18
04/17
07:18
04/17/18
07:18
Recommendations
Nektar, Bristol-Myers, Merck analyst commentary at H.C. Wainwright »

H.C. Wainwright remains…

NKTR

Nektar

$93.50

-6.98 (-6.95%)

BMY

Bristol-Myers

$54.08

-4.56 (-7.78%)

MRK

Merck

$58.66

1.48 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 23

    Apr

  • 24

    Apr

  • 26

    Apr

  • 27

    Apr

  • 01

    May

  • 03

    May

  • 08

    May

  • 21

    May

  • 05

    Jun

  • 12

    Jun

  • 10

    Jul

  • 23

    Oct

NKTR

Nektar

$93.50

-6.98 (-6.95%)

, BMY

Bristol-Myers

$54.08

-4.56 (-7.78%)

05:44
04/17/18
04/17
05:44
04/17/18
05:44
Recommendations
Nektar, Bristol-Myers, Merck analyst commentary at Mizuho »

Keutruda data has no…

NKTR

Nektar

$93.50

-6.98 (-6.95%)

BMY

Bristol-Myers

$54.08

-4.56 (-7.78%)

MRK

Merck

$58.66

1.48 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 23

    Apr

  • 24

    Apr

  • 26

    Apr

  • 27

    Apr

  • 01

    May

  • 03

    May

  • 08

    May

  • 21

    May

  • 05

    Jun

  • 12

    Jun

  • 10

    Jul

  • 23

    Oct

BMY

Bristol-Myers

$54.08

-4.56 (-7.78%)

05:42
04/17/18
04/17
05:42
04/17/18
05:42
Downgrade
Bristol-Myers rating change at Morgan Stanley »

Bristol-Myers downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    May

  • 21

    May

  • 10

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.